← 所有术语
类别: SAFETY SURVEILLANCE

AEMS（不良事件监测系统）

FDA于2026年3月推出的统一不良事件平台，取代MAUDE、FAERS、VAERS等7个旧系统。AEMS在单一仪表板中为所有FDA监管产品提供实时报告。

Last reviewed 2026-08-05 · Reviewed by MedFlux Editorial Board · Editorial policy

Expanded process notes below are currently maintained in English; the short definition above is localized. See our editorial policy.

WHEN IT APPLIES

AEMS is FDA’s 2026 unified adverse event platform consolidating legacy systems including MAUDE for devices. RA/quality teams should plan monitoring workflows for the transition.

PROCESS / STEPS

  1. Map current MAUDE/openFDA queries to AEMS capabilities as published.
  2. Update SOPs for searching and archiving AE evidence.
  3. Train teams on timelines and API changes.
  4. Keep dual-monitoring during transition windows.

EXAMPLES

  • Cross-product signals (drug-device) are a stated goal of unified surveillance.

RELATED GUIDES & TOOLS

SOURCES

Track regulatory signals related to AEMS（不良事件监测系统） across 27 authorities in real time.

START FREE →

相关术语

MAUDE数据库不良事件MedWatch